abstract |
The present invention inhibits JAK and is useful in the treatment of autoimmune and inflammatory diseases, wherein formula (I) wherein the variables: R 1 , R 2 , R 3 , R 4 and R 5 are And the use of the novel pyrrolopyrazinyl urea derivatives (as defined herein). |